Avrix Pharmasp. z o.o.
Overview
Financials
The financial statement for 2024 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2023.
Results vs industry
Industry
Bank accounts
Was a VAT taxpayer from 2012-03-28 to 2025-04-08. Removed from VAT register
Reason for removal: Art. 96 ust. 9 pkt 2 (contact with the taxpayer or their representative is impossible despite documented attempts)
Debt
22 closed proceedings recorded in KRZ history. Closed proceedings in history
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Jun 28, 2023 | Discontinued enforcement proceedings | Closed | |
| Jun 28, 2023 | Discontinued enforcement proceedings | Closed | |
| Jun 28, 2023 | Discontinued enforcement proceedings | Closed | |
| Jun 28, 2023 | Discontinued enforcement proceedings | Closed | |
| Sep 26, 2022 | Discontinued enforcement proceedings | Closed |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Avrix Pharma currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2019.
| Mark | Protected until | |
|---|---|---|
| NATALIS(word) | – |
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations of will on behalf of the company are made by the member of the one-person management board. In the case of a management board consisting of two or more members, declarations of will on behalf of the company require the joint action of two members of the management board, or one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Leszek Józef Nowicki (55) | 95 | $76,985.41 | 95% |
Others | 5 | $4,051.86 | 5% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| City Cosmeticssp. z o.o. | $4,371,889.50 | city-cosmetics.pl | ||
| Organic LifeS.A. | $1,544,477.74 | organiclife.com.pl | ||
| FerrumlabsS.A. | $251,102.52 | truemenskincare.com | ||
| SEE My Aurasp. z o.o. | $233,261.04 | auradistribution.pl | ||
| Mycode Beautysp. z o.o. | $194,102.34 | wwww.mycodebeauty.com | ||
| Kabos Cosmeticssp. z o.o. | $25,287.53 | kabos.pl | ||
| BY Corelsp. z o.o. | $22,392.81 | bycorel.com | ||
| Nakoiosp. z o.o. | $5,999.46 | nakoio.com | ||
| Admedicsp. z o.o. | $4,842.61 | admedic.pl | ||
| Criniesp. z o.o. | $0.25 | criniebeauty.com |
FAQ
Last updated: 2026-04-22